Cuprina Holdings (Cayman) Limited(CUPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CUPR Cuprina Holdings (Cayman) Limited

交易中 08-11 14:06:12 EDT

3.00

-0.04

-1.32%

最高3.15	最低3.00	成交量1.04万
今开3.09	昨收3.04	日振幅4.78%
总市值804.38万	流通市值276.19万	总股本268.13万
成交额3.19万	换手率1.13%	流通股本92.06万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CUPR","market":"US","secType":"STK","nameCN":"Cuprina Holdings (Cayman) Limited","latestPrice":3,"timestamp":1786468087781,"preClose":3.04,"halted":0,"volume":10393,"delay":0,"changeRate":-0.013157894736842117,"floatShares":920624,"shares":2681250,"eps":-1.419903,"marketStatus":"交易中","change":-0.04,"latestTime":"08-11 14:06:12 EDT","open":3.09,"high":3.1453,"low":3,"amount":31892.0834767,"amplitude":0.047796,"askPrice":3.17,"askSize":100,"bidPrice":2.96,"bidSize":162,"shortable":0,"etf":0,"ttmEps":-1.419903,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786478400000},"marketStatusCode":2,"adr":0,"listingDate":1724644800000,"exchange":"NASDAQ","adjPreClose":3.04,"preHourTrading":{"tag":"盘前","latestPrice":2.9775,"preClose":3.04,"latestTime":"07:00 EDT","volume":3275,"amount":9743.5104675,"timestamp":1786446056568,"change":-0.0625,"changeRate":-0.020559,"amplitude":0.044474},"postHourTrading":{"tag":"盘后","latestPrice":3.04,"preClose":3.04,"latestTime":"19:34 EDT","volume":315,"amount":958.04,"timestamp":1786404846378,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.652909},"requestUrl":"/m/hq/s/CUPR","defaultTab":"news","newsList":[{"id":"1178314995","title":"Cuprina获美国FDA 510(k)批准：Medifly蛆成为首个获美许可的铜绿蝇幼虫清创产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1178314995","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178314995?lang=zh_cn&edition=full","pubTime":"2026-06-15 21:01","pubTimestamp":1781528508,"startTime":"0","endTime":"0","summary":"Cuprina Holdings (Cayman) Limited旗下产品Medifly蛆已获得美国食品药品监督管理局的510(k)许可。这是美国市场首次批准一款基于铜绿蝇幼虫的清创治疗产品。该许可标志着该公司在医疗生物技术领域取得了一项重要监管里程碑，为其产品进入美国市场铺平了道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CUPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152256705","title":"Cuprina Holdings宣布完成反向股票分割并请求纳斯达克听证小组举行听证会以维持上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1152256705","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152256705?lang=zh_cn&edition=full","pubTime":"2026-05-30 00:55","pubTimestamp":1780073715,"startTime":"0","endTime":"0","summary":"Cuprina Holdings宣布，公司已完成反向股票分割操作。与此同时，为维持其在纳斯达克市场的上市资格，公司已正式请求纳斯达克听证小组举行听证会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUPR","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637341970","title":"Cuprina宣布1比8反向拆股，以保住纳斯达克上市资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2637341970","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637341970?lang=zh_cn&edition=full","pubTime":"2026-05-23 03:42","pubTimestamp":1779478927,"startTime":"0","endTime":"0","summary":"新加坡生物医疗公司Cuprina Holdings于5月22日宣布，将对其A类和B类普通股实施1比8的反向拆股，预计于5月27日前后生效。此举旨在使公司股价重新达到纳斯达克的最低1美元竞价要求，从而维持上市地位。　　公司首席执行官David Quek表示，此举是维持公司纳斯达克上市地位、增强长期财务灵活性的重要一步。　　此次反向拆股不会改变任何股东的持股比例，但该公司的基本面挑战依然严峻。此外，其市值已跌至约600万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-23/doc-inhyvhtz7330270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4198","CUPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110619698","title":"Cuprina Holdings (Cayman) Limited宣布1股合8股并股计划 预计于2026年5月27日左右生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1110619698","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110619698?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:51","pubTimestamp":1779461475,"startTime":"0","endTime":"0","summary":"Cuprina Holdings (Cayman) Limited 公布了一项股份合并计划。根据该计划，公司将以每八股现有股份合并为一股新股份的比例进行并股。此项并股预计将于2026年5月27日或前后正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUPR","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609542529","title":"Cuprina Holdings (Cayman) Limited盘中异动 大幅跳水5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609542529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2609542529?lang=zh_cn&edition=full","pubTime":"2026-02-06 23:09","pubTimestamp":1770390563,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日23时09分，Cuprina Holdings  Limited股票出现波动，股价快速下挫5.83%。Cuprina Holdings  Limited股票所在的医疗设备行业中，整体涨幅为0.89%。其相关个股中，Pulse Biosciences, Inc、Envista Holdings Corporation、Regentis Biomaterials Ltd.涨幅较大，Glucotrack, Inc.、Ekso Bionics Holdings, Inc.、Envista Holdings Corporation较为活跃，换手率分别为6.98%、1.48%、1.23%，振幅较大的相关个股有Sharps Technology Inc C/Wts 、Pulse Biosciences, Inc、Glucotrack, Inc.，振幅分别为39.18%、29.99%、10.38%。Cuprina Holdings  Limited公司简介：Cuprina Holdings  Ltd是一家生物医学和生物技术公司，致力于慢性伤口管理产品的开发和商业化，以及在健康和美容领域开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020623092397a53c77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020623092397a53c77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","CUPR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cuprina.com","stockEarnings":[{"period":"1week","weight":0.0519},{"period":"1month","weight":-0.3883},{"period":"3month","weight":0.5323},{"period":"6month","weight":-0.13},{"period":"1year","weight":-0.9537},{"period":"ytd","weight":-0.0502}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.1172},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1336}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cuprina Holdings (Cayman) Limited于2023年9月22日在开曼群岛法律下注册成立为豁免公司，总部位于新加坡。该公司是一家总部位于新加坡的生物医学和生物技术公司，致力于开发和商业化用于慢性伤口管理的产品，并经营健康和美容领域业务。公司制造和分销以MEDIFLY品牌销售的医用级无菌蛆虫生物敷料产品，用于蛆虫清创疗法，并拥有包括胶原蛋白敷料、碘基局部抗菌产品和医用水蛭产品在内的慢性伤口护理产品管线。","exchange":"NASDAQ","name":"Cuprina Holdings (Cayman) Limited","nameEN":"Cuprina Holdings (Cayman) Limited"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cuprina Holdings (Cayman) Limited(CUPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cuprina Holdings (Cayman) Limited(CUPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cuprina Holdings (Cayman) Limited,CUPR,Cuprina Holdings (Cayman) Limited股票,Cuprina Holdings (Cayman) Limited股票老虎,Cuprina Holdings (Cayman) Limited股票老虎国际,Cuprina Holdings (Cayman) Limited行情,Cuprina Holdings (Cayman) Limited股票行情,Cuprina Holdings (Cayman) Limited股价,Cuprina Holdings (Cayman) Limited股市,Cuprina Holdings (Cayman) Limited股票价格,Cuprina Holdings (Cayman) Limited股票交易,Cuprina Holdings (Cayman) Limited股票购买,Cuprina Holdings (Cayman) Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cuprina Holdings (Cayman) Limited(CUPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cuprina Holdings (Cayman) Limited(CUPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}